A Look At Healthpeak Properties (DOC) Valuation After 2025 Results And New Earnings Guidance

Simply Wall St

Sun, February 15, 2026 at 1:08 AM GMT+9 3 min read

In this article:

DOC

+3.22%

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.

Healthpeak Properties (DOC) is in focus after releasing its fourth quarter and full year 2025 results. The company also provided 2026 earnings guidance that sets a fresh reference point for how investors may assess the healthcare REIT.

See our latest analysis for Healthpeak Properties.

At a share price of $16.70, Healthpeak Properties has seen a 1-day share price return of 2.58%, while its year to date share price return of 3.09% contrasts with a 1-year total shareholder return decline of 9.15%. This suggests that recent momentum has not yet reversed longer term underperformance as investors weigh the earnings update, 2026 guidance and the completed buyback program.

If this healthcare REIT has caught your attention and you are curious about other areas of the market benefiting from similar long term themes, take a look at 25 healthcare AI stocks as a starting point for fresh ideas.

With shares still below analyst targets and the stock trading after a multi year total return decline, the key question now is whether Healthpeak Properties is quietly undervalued or if the market is already pricing in its future growth.

Most Popular Narrative: 17.2% Undervalued

Healthpeak Properties last closed at $16.70, while the most followed narrative pegs fair value closer to $20.17, pointing to a meaningful valuation gap that rests on specific growth and margin assumptions rather than sentiment alone.

The accelerating shift of surgical and specialty care from inpatient hospital settings to outpatient centers, supported by anticipated regulatory changes (CMS inpatient only default reversal), is set to drive sustained tenant demand and pricing power for Healthpeak’s modern, high acuity outpatient medical buildings, which should translate into increased occupancy rates and same store NOI growth.

Read the complete narrative. Read the complete narrative.

Want to understand why a relatively modest revenue growth path still supports a higher fair value? The narrative leans heavily on thicker margins and a future earnings multiple that sits well above sector norms. Curious which specific earnings and share count assumptions have to hold for that to stack up? The full narrative lays out those moving parts in detail without leaving much to guesswork.

Result: Fair Value of $20.17 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, the story could look very different if capital markets stay tight or if key biotech and healthcare tenants struggle, which could pressure occupancy, rent collection, and refinancing costs.

Story Continues  

Find out about the key risks to this Healthpeak Properties narrative.

Build Your Own Healthpeak Properties Narrative

If you would rather weigh the numbers yourself and come to your own conclusion, you can build a custom view of Healthpeak in just a few minutes: Do it your way

A great starting point for your Healthpeak Properties research is our analysis highlighting 3 key rewards and 4 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If you are serious about tightening up your portfolio, do not stop at a single stock. Use targeted screens to surface opportunities that match what you care about most.

Zero in on quality at a sensible price by scanning our list of 53 high quality undervalued stocks that pair fundamentals with a potentially attractive entry point.

Strengthen your income stream by reviewing 13 dividend fortresses, focused on companies offering 5%+ yields with an emphasis on durability.

Dial up resilience by checking 85 resilient stocks with low risk scores, highlighting businesses with lower risk scores that could help smooth out portfolio volatility.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include DOC.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info